Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes

International Journal of Rheumatic Diseases

Volumn 15, Issue 1, 2012, Pages 56-61

  Niccoli, Laura ^a   Nannini, Carlotta ^a   Cassarà, Emanuele ^a   Kaloudi, Olga ^a   Cantini, Fabrizio ^a  

^a Rheumatology Unit   (Italy)

Author keywords

Anemia of inflammation; Ankylosing spondylitis

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; ETANERCEPT; HEMOGLOBIN; INFLIXIMAB; IRON; PARACETAMOL; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ANEMIA; ANEMIA OF INFLAMMATION; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANEMIA; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; ERYTHROCYTE COUNT; ERYTHROCYTE INDICES; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IRON; ITALY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPONDYLITIS, ANKYLOSING; TIME FACTORS; TRANSFERRIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857056333     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01662.x     Document Type: Article

References (17)

1. Khan MA (2002) Update on spondylarthropathies. Ann Intern Med136, 896-907.
2. Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R (2007) Comparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol26, 211-5.
3. Braun J, Bollow M, Neure L, et al. (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum38, 499-505.
4. Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J (2008) The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther10, R104.
5. Adamson JW (2008) The anemia of inflammation/malignancy: mechanisms and management. Hematology Am Soc Hematol Educ Program2008, 159-65.
6. Andrews NC (1999) Disorders of iron metabolism. N Engl J Med341, 1986-95.
7. Fleming MD (2008) The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology Am Soc Hematol Educ Program, 151-8.
8. Swaak A (2006) Anaemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity. J Rheumatol33, 1467-8.
9. Braun J, Baraliakos X, Brandt J, Sieper J (2005) Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Scand J Rheumatol34, 178-90.
10. Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D, ASAS Working Group (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis65, 316-20.
11. World Health Organization (2008) Worldwide Prevalence of Anaemia 1993-2005. World Health Organization, Geneva. ISBN 9789241596657. Retrieved 25 March 2009.
12. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum27, 361-8.
13. Wilkinson M, Bywaters EGL (1958) Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases. Ann Rheum Dis17, 209-28 (Quoted by: Golding DN (1973) Haematology and biochemistry of ankylosing spondylitis. Br Med J 2, 663).
14. Marks SH, Barnett M, Calin A (1983) Ankylosing spondylitis in women and men: a case-control study. J Rheumatol10, 624-8.
15. Burgos-Vargas R, Naranjo A, Castillo J, Katona G (1989) Ankylosing spondylitis in the Mexican Mestizo: patterns of disease according to age at onset. J Rheumatol16, 186-91.
16. Falkenbach A, Herold M, Wigand R (2000) Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year?Rheumatol Int19, 149-51.
17. Gratacos J, Collado A, Filella X, et al. (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol33, 927-31.